Convergent QSAR studies on a series of NK3 receptor antagonists for schizophrenia treatment (2016)
- Authors:
- USP affiliated authors: YAGUI, CARLOTA DE OLIVEIRA RANGEL - FCF ; TROSSINI, GUSTAVO HENRIQUE GOULART - FCF
- School: FCF
- DOI: 10.3109/14756366.2015.1021250
- Subjects: RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA; RECEPTORES; ESQUIZOFRENIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Enzyme Inhibition and Medicinal Chemistry
- ISSN: 1475-6366
- Volume/Número/Paginação/Ano: v. 31, n. 2, p. 283-294, 2016
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
PRIMI, Marina Candido et al. Convergent QSAR studies on a series of NK3 receptor antagonists for schizophrenia treatment. Journal of Enzyme Inhibition and Medicinal Chemistry, v. 31, n. 2, p. 283-294, 2016Tradução . . Acesso em: 04 jul. 2022. -
APA
Primi, M. C., Maltarollo, V. G., Magalhães, J. G. de, Sá, M. M. de, Rangel-Yagui, C. de O., & Trossini, G. H. G. (2016). Convergent QSAR studies on a series of NK3 receptor antagonists for schizophrenia treatment. Journal of Enzyme Inhibition and Medicinal Chemistry, 31( 2), 283-294. doi:10.3109/14756366.2015.1021250 -
NLM
Primi MC, Maltarollo VG, Magalhães JG de, Sá MM de, Rangel-Yagui C de O, Trossini GHG. Convergent QSAR studies on a series of NK3 receptor antagonists for schizophrenia treatment. Journal of Enzyme Inhibition and Medicinal Chemistry. 2016 ; 31( 2): 283-294.[citado 2022 jul. 04 ] -
Vancouver
Primi MC, Maltarollo VG, Magalhães JG de, Sá MM de, Rangel-Yagui C de O, Trossini GHG. Convergent QSAR studies on a series of NK3 receptor antagonists for schizophrenia treatment. Journal of Enzyme Inhibition and Medicinal Chemistry. 2016 ; 31( 2): 283-294.[citado 2022 jul. 04 ] - Comparison between full and biased agonist's interactions with the angiotensin II type 1 receptor
- Pharmacophore model for biased agonists of angiotensin II receptor type 1: a molecular modeling study
- Comparison between full and biased agonist's interactions with the angiotensin II type 1 receptor
- Biased agonist TRV027 determinants in AT1R by molecular dynamics simulations
- In silico study of the binding mode of biased agonists of the angiotensin II type 1 receptor (AT1)
- Building and validation of a pharmacophore model of LSD-1 inhibitors for virtual screening
- Synthesis, molecular modeling and docking studies of nitrofurazone analogues as trypanomicine candidates
- Construction and validation of the CPB2.8 model and pharmacophore model design of cysteine proteases
- Synthesis of inhibitors of sirtuin 2 for chagas disease
- An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors
Informações sobre o DOI: 10.3109/14756366.2015.1021250 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
